The Enterprise Value as of December 2025 (TTM) for Knight Therapeutics Inc. (KHTRF) is 640.11M

According to Knight Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 640.11M. This represents a change of 13.50% compared to the average of 563.98M of the last 4 quarters.

Knight Therapeutics Inc. (KHTRF) Historical Enterprise Value (quarterly & annually)

How has KHTRF Enterprise Value performed in the past?

The mean historical Enterprise Value of Knight Therapeutics Inc. over the last ten years is 658.56M. The current 640.11M Enterprise Value has changed 9.62% with respect to the historical average. Over the past ten years (40 quarters), KHTRF's Enterprise Value was at its highest in in the December 2016 quarter at 1.02B. The Enterprise Value was at its lowest in in the September 2015 quarter at 428.12M.

Knight Therapeutics Inc. (KHTRF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Knight Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Knight Therapeutics Inc. (KHTRF) Average Enterprise Value

How has KHTRF Enterprise Value performed in the past?

The current Enterprise Value of Knight Therapeutics Inc. (KHTRF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Knight Therapeutics Inc. (KHTRF) Enterprise Value vs. Peers

How is KHTRF’s Enterprise Value compared to its peers?

Knight Therapeutics Inc.’s Enterprise Value is less than Hua Medicine (Shanghai) Ltd. (2.16B), less than Cresco Labs Inc. (780.49M), greater than Verano Holdings Corp. (347.99M), greater than PureTech Health plc (151.84M), less than Surgical Science Sweden AB (publ) (1.11B), greater than Allergy Therapeutics plc (519.12M), greater than Avacta Group Plc (352.66M), greater than COLTENE Holding AG (345.87M), greater than Vitalhub Corp. (454.51M), less than BioInvent International AB (publ) (1.43B),

Build a custom stock screener for Knight Therapeutics Inc. (KHTRF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Knight Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Knight Therapeutics Inc. (KHTRF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Knight Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.